Need professional-grade analysis? Visit stockanalysis.com
$93.34M
N/A
N/A
N/A
Q32 Bio Inc (QTTB) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $6.65, up 3.58% from the previous close.
Over the past year, QTTB has traded between a low of $1.36 and a high of $7.30. The stock has gained 259.5% over this period. It is currently 8.9% below its 52-week high.
Q32 Bio Inc has a market capitalization of $93.34M.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Side-by-side comparison against top Healthcare peers.